ARE THE CURRENT MANAGEMENT STRATEGIES FOR T1/T2 N0 OESOPHAGEAL CANCER OPTIMAL?

被引：0
|
作者：
Evans, R. [1 ]
Evans, J. P. [1 ]
Kirby, G. [1 ]
Curran, F. [2 ]
Cheruvu, C. V. N. [1 ]
机构：
[1] Univ Hosp North Midlands, Stoke On Trent, Staffs, England
[2] Royal Wolverhampton Hosp NHS Trust, Wolverhampton, England
来源：
GUT | 2015年 / 64卷
关键词：
D O I：
10.1136/gutjnl-2015-309861.1039
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PTH-151
引用
收藏
页码：A475 / A475
页数：1
相关论文
共 50 条
  • [1] ARE THE CURRENT MANAGEMENT STRATEGIES FOR T1/T2 N0 OESOPHAGEAL CANCER OPTIMAL?
    Evans, J.
    Pande, R.
    Beardsmore, D.
    Corless, D.
    Crisp, W.
    Cheruvu, C.
    [J]. GUT, 2012, 61 : A262 - A262
  • [2] Endocavitary contact radiation therapy for ultrasonographically staged T1 N0 and T2 N0 rectal cancer
    Christoforidis, D.
    McNally, M. P.
    Jarosek, S. L.
    Madoff, R. D.
    Finne, C. O.
    [J]. BRITISH JOURNAL OF SURGERY, 2009, 96 (04) : 430 - 436
  • [3] Is prophylactic neck dissection mandatory in T1/T2 N0 oral cancer patients?
    El-Naaj, I. A.
    Leiser, Y.
    Shveis, M.
    Peled, M.
    [J]. ORAL ONCOLOGY, 2009, : 114 - 114
  • [4] Establishing current UK radiotherapy treatment volumes and dose for early glottic larynx cancer (T1/T2 N0)
    Chennupati, Jyothsna
    Beasley, Matthew
    Al-Booz, Hoda
    [J]. CLINICAL ONCOLOGY, 2019, 31 : E8 - E8
  • [5] Outcomes of chemoradiotherapy plus local excision in patients with clinical T1 or T2, N0 rectal cancer
    Suzuki, T.
    Sadahiro, S.
    Ogimi, T.
    Miyakita, H.
    Saito, G.
    Okada, K.
    Tanaka, A.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [6] Photodynamic Therapy Outcome for T1/T2 N0 Oral Squamous Cell Carcinoma
    Jerjes, Waseem
    Upile, Tahwinder
    Hamdoon, Zaid
    Mosse, Charles Alexander
    Morcos, Mira
    Hopper, Colin
    [J]. LASERS IN SURGERY AND MEDICINE, 2011, 43 (06) : 463 - 469
  • [7] RESULTS OF RADIATION-THERAPY IN EARLY GLOTTIC CARCINOMA (T1, T2 N0)
    STEIN, M
    ROSENBLATT, E
    KUTEN, A
    COHEN, Y
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1989, 40 (03) : 173 - 176
  • [8] Protein tyrosine kinase activity in 350 T1/T2, N0/N1 breast cancer. Preliminary results
    Bolla, M
    RostaingPuissant, B
    Bottari, SP
    Chedin, M
    MarronCharriere, J
    Colonna, M
    Berland, E
    Chambaz, EM
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 649 - 649
  • [9] Protein tyrosine kinase activity in 350 T1/T2, N0/N1 breast cancer. Preliminary results
    Bolla, M
    RostaingPuissant, B
    Bottari, SP
    Chedin, M
    MarronCharriere, J
    Colonna, M
    Berland, E
    Chambaz, E
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1996, 39 (03) : 327 - 334
  • [10] Role of Selective Neck Dissection in Primary T1, T2, N0 Neck Oral Tongue Carcinoma
    Islam, Mohammad Nazrul
    Salam, Kazi Shameemus
    Siddique, Belayat Hossain
    Rahman, Md Lutfor
    Islam, Rashedul
    Faruquzzaman, G. M.
    Sohel, Shah
    Sakender, Md Shah
    [J]. BANGLADESH JOURNAL OF OTORHINOLARYNGOLOGY, 2021, 27 (02): : 130 - 138
12345